MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Regen BioPharma Inc (RGBP)
Regen BioPharma Inc (RGBP)
source: myfinsight.com
Download
Download image
Derivative income
(expense)
$1,181,680
(816.29%↑ Y/Y)
Total other income
(expense), net
$1,145,636
(1118.83%↑ Y/Y)
Interest expense
$27,388
(22.66%↑ Y/Y)
Interest expense
attributable to amortization...
$8,656
(-31.51%↓ Y/Y)
Nonrelated Party
$31,640
(0.00%↑ Y/Y)
Related Party
$27,425
(0.00%↑ Y/Y)
Net profit (loss)
before income taxes
$991,927
(5225.18%↑ Y/Y)
Profit (loss) from
operations
-$153,709
(-35.61%↓ Y/Y)
Net revenue
$59,065
(0.00%↑ Y/Y)
Net profit (loss)
$991,927
(5225.18%↑ Y/Y)
Total operating
expenses
$212,774
(23.41%↑ Y/Y)
Consulting and
professional fees
$178,454
(30.67%↑ Y/Y)
General and
administrative
$32,104
(140.52%↑ Y/Y)
Research and development
$2,216
Back